Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Daiichi Suntory Pharma (Rights To 6R-BH4)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

A drug development and marketing right in Japan. The drug development right is associated to treat cardiovascular indications and genetic disease phenylketonuria (PKU).

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Primary Office
  • Daiichi Sankyo Building A/B 3-5-1
  • Nihonbashi-honcho
  • Tokyo, 103-8426
  • Japan

Daiichi Suntory Pharma (Rights To 6R-BH4) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Daiichi Suntory Pharma (Rights To 6R-BH4)‘s full profile, request access.

Request full access to PitchBook

Daiichi Suntory Pharma (Rights To 6R-BH4) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Daiichi Suntory Pharma (Rights To 6R-BH4)‘s full profile, request access.

Request full access to PitchBook